Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Farlow

Showing results (51-60 of 189) with videos related to

Pageof 19
Sort By:
Clinical Neuropharmacology|December 20, 2007
Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretaseEric R Siemers, Robert A Dean, Stuart Friedrich, et al.
Journal of Child Neurology|September 5, 2006
High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggressionDeborah K Sokol, Demao Chen, Martin R Farlow, et al.
Neuroscience Letters|December 21, 2010
Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic miceHuiying Gu, Xing Wei, Andrew D Monnot, et al.
Toxicology Letters|July 17, 2012
Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposureHuiying Gu, Gregory Robison, Lan Hong, et al.
Dementia and Geriatric Cognitive Disorders|November 30, 2011
Association of clusterin gene polymorphisms with late-onset Alzheimer's diseaseHuiying Gu, Xing Wei, Shirley Chen, et al.
Neurology|November 6, 2015
Raloxifene for women with Alzheimer disease: A randomized controlled pilot trialVictor W Henderson, Tom Ala, Kristin L Sainani, et al.
Clinical Neuropharmacology|April 9, 2010
Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer diseaseEric R Siemers, Stuart Friedrich, Robert A Dean, et al.
Alzheimer'S Research & Therapy|April 29, 2015
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's diseaseMartin R Farlow, Niels Andreasen, Marie-Emmanuelle Riviere, et al.
American Journal of Alzheimer'S Disease and Other Dementias|August 23, 2007
Depressed mood in informal caregivers of individuals with mild cognitive impairmentYueh-Feng Yvonne Lu, Mary Guerriero Austrom, Susan M Perkins, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 13, 2005
Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injuryJiangning Tan, Zhizhong Ma, Ling Han, et al.
Pageof 19

Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Clinical Neuropharmacology|December 20, 2007
Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretaseEric R Siemers, Robert A Dean, Stuart Friedrich, et al.
Journal of Child Neurology|September 5, 2006
High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggressionDeborah K Sokol, Demao Chen, Martin R Farlow, et al.
Neuroscience Letters|December 21, 2010
Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic miceHuiying Gu, Xing Wei, Andrew D Monnot, et al.
Toxicology Letters|July 17, 2012
Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposureHuiying Gu, Gregory Robison, Lan Hong, et al.
Dementia and Geriatric Cognitive Disorders|November 30, 2011
Association of clusterin gene polymorphisms with late-onset Alzheimer's diseaseHuiying Gu, Xing Wei, Shirley Chen, et al.
Neurology|November 6, 2015
Raloxifene for women with Alzheimer disease: A randomized controlled pilot trialVictor W Henderson, Tom Ala, Kristin L Sainani, et al.
Clinical Neuropharmacology|April 9, 2010
Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer diseaseEric R Siemers, Stuart Friedrich, Robert A Dean, et al.
Alzheimer'S Research & Therapy|April 29, 2015
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's diseaseMartin R Farlow, Niels Andreasen, Marie-Emmanuelle Riviere, et al.
American Journal of Alzheimer'S Disease and Other Dementias|August 23, 2007
Depressed mood in informal caregivers of individuals with mild cognitive impairmentYueh-Feng Yvonne Lu, Mary Guerriero Austrom, Susan M Perkins, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 13, 2005
Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injuryJiangning Tan, Zhizhong Ma, Ling Han, et al.
Pageof 19